Cargando…

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al

Detalles Bibliográficos
Autores principales: Ieni, Antonio, Barresi, Valeria, Ricciardi, Giuseppina Rosaria Rita, Adamo, Barbara, Adamo, Vincenzo, Tuccari, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998015/
https://www.ncbi.nlm.nih.gov/pubmed/27578997
http://dx.doi.org/10.2147/BCTT.S113577
_version_ 1782449871364554752
author Ieni, Antonio
Barresi, Valeria
Ricciardi, Giuseppina Rosaria Rita
Adamo, Barbara
Adamo, Vincenzo
Tuccari, Giovanni
author_facet Ieni, Antonio
Barresi, Valeria
Ricciardi, Giuseppina Rosaria Rita
Adamo, Barbara
Adamo, Vincenzo
Tuccari, Giovanni
author_sort Ieni, Antonio
collection PubMed
description
format Online
Article
Text
id pubmed-4998015
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-49980152016-08-30 Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al Ieni, Antonio Barresi, Valeria Ricciardi, Giuseppina Rosaria Rita Adamo, Barbara Adamo, Vincenzo Tuccari, Giovanni Breast Cancer (Dove Med Press) Letter Dove Medical Press 2016-08-19 /pmc/articles/PMC4998015/ /pubmed/27578997 http://dx.doi.org/10.2147/BCTT.S113577 Text en © 2016 Ieni et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Letter
Ieni, Antonio
Barresi, Valeria
Ricciardi, Giuseppina Rosaria Rita
Adamo, Barbara
Adamo, Vincenzo
Tuccari, Giovanni
Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_full Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_fullStr Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_full_unstemmed Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_short Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
title_sort prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “triple-negative breast cancer: treatment challenges and solutions” by collignon et al
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998015/
https://www.ncbi.nlm.nih.gov/pubmed/27578997
http://dx.doi.org/10.2147/BCTT.S113577
work_keys_str_mv AT ieniantonio prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewabouttriplenegativebreastcancertreatmentchallengesandsolutionsbycollignonetal
AT barresivaleria prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewabouttriplenegativebreastcancertreatmentchallengesandsolutionsbycollignonetal
AT ricciardigiuseppinarosariarita prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewabouttriplenegativebreastcancertreatmentchallengesandsolutionsbycollignonetal
AT adamobarbara prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewabouttriplenegativebreastcancertreatmentchallengesandsolutionsbycollignonetal
AT adamovincenzo prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewabouttriplenegativebreastcancertreatmentchallengesandsolutionsbycollignonetal
AT tuccarigiovanni prognosticvalueofandrogenreceptorexpressionintriplenegativebreastcarcinomaspersonalexperienceandcommentsonareviewabouttriplenegativebreastcancertreatmentchallengesandsolutionsbycollignonetal